• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变种(B.1.1.529)感染后的死亡率:它的致命性如何?一项系统评价和荟萃分析。

Fatality Rates After Infection With the Omicron Variant (B.1.1.529): How Deadly has it been? A Systematic Review and Meta-Analysis.

作者信息

Ahmad Suhaib Js, Degiannis Jason R, Borucki Joseph, Pouwels Sjaak, Rawaf David Laith, Lala Anil, Whiteley Graham S, Head Marion, Simpson Angharad, Archid Rami, Ahmed Ahmed R, Soler J Agustin, Wichmann Doerte, Thangavelu Mohanarangam, Abdulmajed Mohamed, Elmousili Mahmoud, Lin Yan-Ren, Gelber Edgar, Exadaktylos Aristomenis K

机构信息

Betsi Cadwaladr University Health Board Department of General Surgery Wales UK.

University Hospital of Bern Department of Emergency Medicine Inselspital Switzerland.

出版信息

J Acute Med. 2024 Jun 1;14(2):51-60. doi: 10.6705/j.jacme.202406_14(2).0001.

DOI:10.6705/j.jacme.202406_14(2).0001
PMID:38855048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11153312/
Abstract

BACKGROUND

Since late 2019, the global community has been gripped by the uncertainty surrounding the SARS-CoV-2 pandemic. In November 2021, the emergence of the Omicron variant in South Africa added a new dimension. This study aims to assess the disease's severity and determine the extent to which vaccinations contribute to reducing mortality rates.

METHODS

A systematic review and meta-analysis of the epidemiological implications of the omicron variant of SARS-CoV-2 were performed, incorporating an analysis of articles from November 2021that address mortality rates.

RESULTS

The analysis incorporated data from 3,214,869 patients infected with omicron, as presented in 270 articles. A total of 6,782 deaths from the virus were recorded (0.21%). In the analysed articles, the pooled mortality rate was 0.003 and the pooled in-house mortality rate was 0.036. Vaccination is an effective step in preventing death (odds ratio: 0.391, < 0.01).

CONCLUSION

The mortality rates for the omicron variant are lower than for the preceding delta variant. mRNA vaccination affords secure and effective protection against severe disease and death from omicron.

摘要

背景

自2019年末以来,全球社会一直笼罩在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行的不确定性之中。2021年11月,南非出现的奥密克戎变异株又增添了新的情况。本研究旨在评估该疾病的严重程度,并确定疫苗接种在降低死亡率方面的作用程度。

方法

对SARS-CoV-2奥密克戎变异株的流行病学影响进行了系统评价和荟萃分析,纳入了对2021年11月以来涉及死亡率的文章的分析。

结果

分析纳入了270篇文章中3,214,869例感染奥密克戎患者的数据。该病毒共造成6,782人死亡(0.21%)。在分析的文章中,汇总死亡率为0.003,汇总院内死亡率为0.036。接种疫苗是预防死亡的有效措施(优势比:0.391,P < 0.01)。

结论

奥密克戎变异株的死亡率低于之前的德尔塔变异株。信使核糖核酸(mRNA)疫苗可为预防奥密克戎导致的重症疾病和死亡提供安全有效的保护。

相似文献

1
Fatality Rates After Infection With the Omicron Variant (B.1.1.529): How Deadly has it been? A Systematic Review and Meta-Analysis.奥密克戎变种(B.1.1.529)感染后的死亡率:它的致命性如何?一项系统评价和荟萃分析。
J Acute Med. 2024 Jun 1;14(2):51-60. doi: 10.6705/j.jacme.202406_14(2).0001.
2
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.既往 SARS-CoV-2 感染对再感染的保护作用:系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
3
The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis.奥密克戎变异株相对于 SARS-CoV-2 的德尔塔变异株感染患者的死亡和重症风险:系统评价和荟萃分析。
Ir J Med Sci. 2023 Dec;192(6):2897-2904. doi: 10.1007/s11845-022-03266-6. Epub 2023 Feb 9.
4
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.奥密克戎变异株与新冠前变异株相比,既往感染 SARS-CoV-2 在预防再感染和 COVID-19 严重并发症方面的作用:系统评价。
BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3.
5
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
6
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.奥密克戎变异株疫苗有效性的系统评价和荟萃分析。
Front Public Health. 2022 Jul 13;10:940956. doi: 10.3389/fpubh.2022.940956. eCollection 2022.
7
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
8
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
9
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.奥密克戎和德尔塔变异株导致的严重急性呼吸综合征冠状病毒 2 的临床结局:33 项研究的系统评价和荟萃分析,涵盖 6037144 例新型冠状病毒疾病 2019 阳性患者。
Clin Microbiol Infect. 2023 Jul;29(7):835-844. doi: 10.1016/j.cmi.2023.03.017. Epub 2023 Mar 18.
10
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.

引用本文的文献

1
The COVID-19 Infection Did Not Aggravate the Mortality of Long-Term Care Facility Residents Under Strict Infection Control and with Immediate Anti-Viral Treatment: Real-World Analysis.在严格感染控制和立即进行抗病毒治疗的情况下,新冠病毒感染并未增加长期护理机构居民的死亡率:真实世界分析
Viruses. 2025 Apr 26;17(5):625. doi: 10.3390/v17050625.
2
SARS-CoV-2 spike protein: structure, viral entry and variants.严重急性呼吸综合征冠状病毒2刺突蛋白:结构、病毒进入及变体
Nat Rev Microbiol. 2025 May 6. doi: 10.1038/s41579-025-01185-8.
3
Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection.环境暴露和家族背景会改变新型冠状病毒感染后神经病理学和炎症的诱导情况。
NPJ Parkinsons Dis. 2025 Apr 23;11(1):86. doi: 10.1038/s41531-025-00925-0.

本文引用的文献

1
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections.估算奥密克戎和德尔塔 SARS-CoV-2 感染的疾病严重程度。
Nat Rev Immunol. 2022 May;22(5):267-269. doi: 10.1038/s41577-022-00720-5.
2
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.南非出现奥密克戎后,SARS-CoV-2 再感染的风险增加。
Science. 2022 May 6;376(6593):eabn4947. doi: 10.1126/science.abn4947.
3
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.美国奥密克戎、德尔塔和阿尔法 SARS-CoV-2 变异株的 mRNA 疫苗对新冠病毒的临床严重程度和有效性:前瞻性观察研究。
BMJ. 2022 Mar 9;376:e069761. doi: 10.1136/bmj-2021-069761.
4
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.南非奥密克戎变异株下的人群免疫力与新冠病毒疾病严重程度。
N Engl J Med. 2022 Apr 7;386(14):1314-1326. doi: 10.1056/NEJMoa2119658. Epub 2022 Feb 23.
5
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
6
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
7
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.COVID-19 发病率和死亡率在有和没有加强针的未接种和完全接种成年人中,在德尔塔和奥密克戎变体出现期间-25 个美国司法管辖区,2021 年 4 月 4 日至 12 月 25 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
8
Impact of lockdown relaxation and implementation of the face-covering policy on mental health: A United Kingdom COVID-19 study.封锁放松及口罩政策实施对心理健康的影响:一项英国新冠疫情研究
World J Psychiatry. 2021 Dec 19;11(12):1346-1365. doi: 10.5498/wjp.v11.i12.1346.
9
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.南非对 SARS-CoV-2 奥密克戎变异株临床严重程度的早期评估:一项数据关联研究。
Lancet. 2022 Jan 29;399(10323):437-446. doi: 10.1016/S0140-6736(22)00017-4. Epub 2022 Jan 19.
10
Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021.2021 年 11 月至 12 月,法国马赛首例 1119 例 SARS-CoV-2 奥密克戎变异株病例的特征。
J Med Virol. 2022 May;94(5):2290-2295. doi: 10.1002/jmv.27613. Epub 2022 Feb 3.